developed HYPERsol by optimizing the techniques of deparaffinization, protein solubilization, and sample preparation to peptides for proteomics analysis. We compared the standard xylene-ethanol deparaffinization procedure ("X") to a procedure in which FFPE cores were directly solubilized in buffer containing 5% SDS ("D").
Protein extraction was performed with either probe sonication ("P") or Covaris AFA ultrasonication ("A"). Protein was recovered and processed for liquid chromatography-mass spectrometry with either Wessel-Flügge methanolchloroform precipitation 8 and in-solution digestion ("M") or with S-Traps ("S") [ Fig 1a,b] .
We first examined the extent of solubilization of FFPE liver samples achieved by each method. Compared to the standard workflow employing xylene-ethanol deparaffinization and probe sonication ("XP") 9 , direct resuspension in 5% SDS buffer followed by AFA sonication ("DA") solubilized >2-fold more protein with a corresponding >2-fold To directly compare the performance of each sample preparation workflow for proteomic analysis against a standard tissue source, we utilized tissue from five human livers. Each sample was split at the time of autopsy: a portion was immediately flash-frozen, and another portion fixed with formalin, processed and embedded according to standard histopathology protocols. For proteomic analysis, samples were run on a Thermo Easy nLC coupled to a Thermo Fusion Tribrid mass spectrometer with a 90-minute data-independent acquisition (DIA) method. Database searching was performed in Spectronaut against a custom spectral library generated by data-dependent acquisition (DDA) analysis of a pooled sample set subject to high pH reverse phase fractionation.
On average, compared to the xylene-ethanol deparaffinization, probe sonication and methanol-chloroform precipitation ("XPM"; "Standard"), the combination of direct 5% SDS solubilization, AFA ultrasonication, and S-Trap sample processing ("DAS"; "HYPERsol") resulted in the identification of 37% more peptides (from 30432 ± 1324 to 41643 ± 1012) which and 24% more protein groups (from 2653 ± 87 to 3297 ± 46), a depth closely approaching that obtained in a flash-frozen sample processed with probe sonication and S-Traps (FPS; 3517 ± 18) [ Supplementary Figure 2a- Figure 2d] . The average protein sequence coverage ranged from 20.0% to 23.9%, with both DPS and HYPERsol enabling statistically significant increases compared to the Standard workflow [ Supplementary   Figure 2e ]. The distribution of gene ontology (GO) component terms was similar across all sample preparation methods, but subtle statistically significant differences were observed when comparing FFPE conditions to FPS. Extracellular, cytoplasmic, and membrane proteins were modestly overrepresented in FFPE samples relative to FPS. These differences were minimized by the HYPERsol method [ Supplementary Figure 2g ,h, Supplementary Table 2] .
Counterintuitively, both the HYPERsol and direct solubilization, probe sonication, S-Trap ("DPS") workflows yielded slightly more peptide identifications (IDs) than the FPS workflow [ Supplementary Figure 2b ]. In addition, there were 4567 peptides identified in both Standard and HYPERsol, but not FPS [ Supplementary Figure 3a] . Further inspection revealed these "extra" peptides to be primarily the result of missed tryptic cleavages of highly abundant proteins, an effect presumably resulting from formalin crosslinking blocking trypsin access. The distribution of grand average of hydropathy (GRAVY) scores across the two sample sets was indistinguishable [ Supplementary Figure 3b- or protein group IDs from the flash-frozen tissue, suggesting that the increased sonication energy afforded by AFA is only obligatory when solubilizing protein from FFPE. Nevertheless, given the improved performance of AFA relative to probe sonication in the other conditions, we considered the FAS dataset as the ground truth dataset for subsequent comparisons.
In order to compare the similarity of the proteomic datasets generated via each sample preparation workflow, we examined the Pearson correlation coefficients among the protein quantification tables derived from each workflow Nevertheless Table   9 ]. For example, S100A and S100B were highly overexpressed in melanomas relative to both MPNSTs and synovial sarcomas, consistent with the longstanding use of S100 as an IHC marker for melanoma, and the loss of S100 expression seen in MPNST as compared to benign nerve sheath tumors [ Figure 2e , Supplementary Figure 4b] 15, 16 Additionally, TLE1, a widely-used marker for synovial sarcoma, was indeed detected in all synovial sarcomas 17 .
However, in line with reports that TLE1 is not entirely specific for synovial sarcoma, TLE1 expression was also observed in 9/10 melanomas and 12/13 MPNSTs 18 . Though statistically significant, on average it was only approximately 3-fold more highly expressed in synovial sarcoma relative to MPNST, an expression difference that further underscores the need for better markers to distinguish between these two tumors [Supplementary Figure   4a ]. Importantly, this experiment revealed several proteins that were entirely tumor-type specific (90 in MPNST, 54 in melanoma, and 12 in synovial sarcoma; [Supplementary Table 9] ). Future work will establish whether these are useful IHC markers for these diagnostically challenging tumors.
In conclusion, HYPERsol enables highly reproducible protein identification and quantification from FFPE tissue, yielding results that are highly similar to flash-frozen tissue. The combination of direct SDS solubilization, AFA ultrasonication and S-Trap sample processing markedly increases protein yield, potentially enabling analysis of small samples such as core needle biopsies or samples obtained by laser-capture microdissection. We anticipate that the reduced variability of HYPERsol sample processing will enhance the capacity of researchers to extract meaningful biologic information from FFPE samples by minimizing sample preparation-induced artifacts. In addition, the approach is rapid and obviates the need for time-consuming, tedious and toxic deparaffinization: samples can now be easily prepared to peptides and analyzed on the same day. With the availability of 96-well plates for AFA and S-Trap sample processing, HYPERsol is suited to automated, high-throughput analyses essential for clinical implementation. We thus anticipate that the HYPERsol workflow will enable novel discoveries from rich clinicallyannotated and histologically-characterized FFPE biorepositories worldwide, thereby helping to usher in a new era of clinical proteomics.
Methods

IRB statement
Human samples were collected under protocols approved by the Institutional Review Board (IRB) of the University of Pennsylvania or documented as exempt from IRB review. All samples were subjected to histopathologic review for confirmation of diagnosis and selection of the region for tissue isolation.
Tissue processing
Automated tissue processing was carried out in a Leica Peloris II processor (Leica Biosystems) with the following incubation settings: 60 min 10% neutral buffered formalin, 60 min formalin 10% neutral buffered formalin, 80%
EtOH 20 minutes, 95% EtOH 60 minutes, 100% EtOH 30 minutes, 100% EtOH 50 minutes, 100% EtOH 60 minutes, xylene 30 minutes, xylene 50 minutes, xylene 60 minutes, paraffin 60 minutes, paraffin 60 minutes, paraffin 60 minutes. Following processing, samples were embedded in paraffin and stored in blocks at room temperature prior to processing.
Hematoxylin & Eosin staining
The original diagnostic histologic sections were used for confirmation of diagnosis and for the photomicrographs shown in Figure 2 . These were standard 5 μm tissue sections stained with hematoxylin/eosin according to standard histopathology protocols. Digital images were taken on a Leica DMC 4500 camera and captured and processed using the Leica Digital Application Suite v4.12.
Deparaffinization/solubilization
Xylene/ethanol: Tissue cores were diced into small pieces and resuspended in 10 x volume (based on dry weight) of xylene and incubated at 37 °C for 10 minutes with gentle agitation. Following centrifugation and removal of xylene, the process was repeated with xylene and then with 100% ethanol twice, 95% ethanol, 85%, 70%, 50%, 20%, and then water. Samples were then resuspended in solubilization buffer containing 5% SDS and 100 mM Tris pH 8.5, and homogenized with a mortar and pestle. Samples were then passed through an 18-gauge needle 10x, then a 21-gauge needle 10x. Following sonication (as described below), the process was repeated. The homogenized lysate was then spun down at 16,000 x g in a benchtop centrifuge for 15 minutes. The soluble fraction was transferred to a separate tube and the total protein concentration was measured using a BCA assay (Pierce).
Direct solubilization: Cores were resuspended in 20x volume/weight of solubilization buffer containing 5% SDS and 100 mM Tris pH 8.5, and incubated at 50 °C for 10 min. The pellet was homogenized with a micropestle, then passed through an 18-gauge needle 10x, followed by a 21-gauge needle 10x. Following sonication as described below, the samples were placed on a heat block at 80 °C for 1 hr. The samples were removed and the sonication was repeated.
The samples were returned to the heating block for 1 hr. The homogenized lysate was then spun down at 16,000 x g in a benchtop centrifuge for 15 minutes. The soluble fraction was transferred to a separate tube and the total protein concentration was measured using a BCA assay (Pierce).
Sonication
Probe: For probe sonication, the homogenized lysate was subjected to benchtop sonication with a Thermo Fisher probe sonicator with a microtip, 3 x 30 s pulses, 20% power, and with a 50% duty ratio. Two rounds of sonication were performed as described above.
AFA: Samples were analyzed on a Covaris S220 AFA in screw-cap microTUBEs (PN500339). The general parameters were as follows: water level set point 15, chiller set point 18 °C, holder, peak incident power 175 W, duty factor 10%, cycles per burst 200, instrument temperature 20 °C. Two rounds of sonication were performed; in the first round (emulsification), the treatment time was 300 s. In the second round (solubilization), the treatment time was 360 s.
Tissue yield
To calculate tissue yield and percent solubilized for each tissue type depicted in Figure S2 , dried 1 mm tissue cores were weighed, then directly placed in solubilization buffer, ground with a mortar and pestle, and allowed to equilibrate for 15 minutes at room temperature. The sample was spun at 16,000 x g in a benchtop centrifuge and the initial supernatant was saved for subsequent BCA assay. The pellets were also weighed and recorded as the resolubilized mass of the FFPE tissue. The samples were then processed according to the HYPERsol protocol, and spun down again at 16,000 x g in a benchtop centrifuge. The supernatant was saved for BCA assay, and the pellet reweighed. The % solubilized was calculated as: 100*(1-((mass of residual pellet after processing)/(mass of starting pellet after equilibration in DAS/HYPERsol buffer))). The yield was calculated as: (protein concentration x volume for the initial resuspension solution + protein concentration x volume for the final, processed sample) / (initial weight of dried FFPE in mg). For all samples, the amount of protein in the initial resuspension/equilibration solution contributed negligibly to the overall yield.
Sample clean-up and preparation for LC-MS
Methanol/chloroform: Samples were processed as previously described 8 . The sample volume containing 100 μg of total protein was adjusted to 300 μl with water. 300 μl of ice-cold methanol was added, and the sample was vortexed briefly. Next, 75 μl of ice-cold chloroform was added and the sample was vortexed again, then immediately centrifuged for 1 min at 9,000 x g on a benchtop centrifuge. Following centrifugation, the upper phase was removed and discarded. 300 μl of ice cold methanol was added and the sample was vortexed again, then spun at 16,000 x g in a benchtop centrifuge. The supernatant was removed without disturbing the pellet, and the tube was left with the cap off for 5 minutes to allow excess methanol to evaporate. The pellet was then resuspended in 20 μl of 6 M urea + 2 M thiourea. Following resuspension, 100 μl of 50 mM ammonium bicarbonate pH 8.0 with 1.2x protease inhibitor cocktail (Pierce) was added, and DTT was added to a final concentration of 10 mM. Samples were incubated for 30 minutes at room temperature. Iodoacetamide was added to a final concentration of 20 mM and samples were incubated in the dark for 30 minutes. An additional 10 mM DTT was added to quench the derivatization reaction, and the samples were digested with trypsin at a 1:50 ratio overnight at room temperature. S-Trap: Prior to loading on the S-Traps, samples were reduced and alkylated as described above. S-Trap trypsin digestion and clean-up was performed according to the manufacturer's instructions. Briefly, 50 μg protein was loaded on S-Trap micro spin columns (C02-micro) and washed extensively with 90% methanol, 100 mM TEAB, pH 7.1. Trypsin was added directly to the microcolumn at a 1:20 ratio in 50 mM TEAB, pH 8, and samples were incubated in a water bath at 47 °C for 1 hr. Peptides were eluted by serial addition of 50 mM TEAB, 0.2% formic acid, and 0.2% formic acid in 50% acetonitrile.
High-pH reversed-phase fractionation: A fraction of the peptides from each sample were pooled and acidified with 0.1% trifluoroacetic acid (TFA). The pooled mix was loaded on a Harvard apparatus Micro SpinColumn (Cat# 74-4601), washed with 0.1% TFA, and eluted with 12 serial additions of 100 mM ammonium formate, pH 10, containing increasing concentrations of acetonitrile (10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 35 , 60% ACN). Fractions were pooled (1+6, 2+7, etc.), dried, and desalted prior to analysis.
Desalting: All samples were resuspended in 0.1% TFA, loaded on homemade C18 stage-tips (3M Empore Discs) and desalted as previously described, with minor modifications 19 . Briefly, columns were conditioned with 100 μl acetonitrile and equilibrated with 100 μl 0.1% TFA. Samples were loaded and the stage-tip was washed with 100 μl 0.1% TFA before peptides were eluted with 100 μl 0.1% formic acid in 60% acetonitrile.
Liquid chromatography
Nanoflow liquid chromatography was performed using either a Thermo Dionex Ultimate 3000 or a Thermo ScientificTM Easy nLC TM 1000 equipped with a 75 µm x 20 cm column packed in-house using Reprosil-Pur C18-AQ (2.4 µm; Dr. Maisch GmbH, Germany). Buffer A was 0.1% formic acid and Buffer B was 0.1% formic acid in 80% acetonitrile. The flow rate was 400 nL/min.
For 90 minute runs (Easy nLC) the gradient was as follows: 2% B for 2 minutes, 18% B over 42 minutes, 40% B over 30 minutes, 46% B over 4 minutes, 55% B over 2 min, 98% B over 10 s, hold 98% B for 9 min 50 s.
For 110 minute runs (Dionex) the gradient was as follows: 5% B for 1 minute, 30% B over 73 minutes, 45% B over 18 minutes, 85% B over 1 minute, hold for 7 minutes, re-equilibrate for 10 minutes.
For 135 minute runs (Easy nLC) the gradient was as follows: 1% B to 4% B over 3 minutes, 6% over 3 minutes, 8% over 4 minutes, 10% over 5 minutes, 12% over 18 minutes, 17% over 9 minutes, 26% over 41 minutes, 28% over 9 minutes, 30% over 6 minutes, 32% over 5 minutes, 34% over 4 minutes, 36% over 4 minutes, 38% over 3 minutes, 41% over 3 minutes, 52% over 3 minutes, 90% over 5 minutes, hold 90% for 10 minutes.
Mass spectrometry
The HPLC was coupled online to either a Thermo Fusion Orbitrap Tribrid or a Thermo Q Exactive HF-X mass spectrometer operating in the positive mode using a Nanospray Flex™ Ion Source (Thermo Scientific) at 2.3 kV. 
Mass spectrometry data analysis
For all liver sample analyses, spectral libraries were generated using Spectronaut Pulsar X with the following settings: digest type = specific, missed cleavage = 2, min peptide length = 7, max peptide length = 52, toggle N-terminal M = true, and using the 2017-10-25 version of the Homo sapiens [SwissProt TaxID=9606] proteome. Liver samples were also analyzed with directDIA and the search archives were used to improve the Pulsar library search. For the methyl and methylol adduct search, these were included as variable modifications. For histologic mimics, the spectral library was generated with Proteome Discoverer 2.3 using the default "PWF_QE_SequestHT_MSAmanda_Percolator" and "CWF_Basic" workflows. The PDRESULT file was converted to a spectral library in Spectronaut Pulsar X with the settings described above.
All DIA runs were analyzed in Spectronaut Pulsar X using BGS Default Factory Settings. Peptide and protein intensities were log2 transformed, and processed by a two-step normalization. First, within each run, the run-level median intensity was subtracted from each measured intensity such that the values were normally distributed around 0. Then the global median intensity from the entire sample set was added back such that all intensity values were positive. No imputation was performed. Figures were generated in R using the packages ggplot2, ggthemes, corrplot, and VennDiagram.
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